SMTL ID : 5oin.1

InhA (T2A mutant) complexed with N-(1-(pyrimidin-2-yl)piperidin-4-yl)acetamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.82 Å

Oligo State

homo-tetramer

Ligands

4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)

NAD.1: 24 residues within 4Å: Chain A: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, M.161, K.165, A.191, G.192, P.193, I.194, T.196, A.198 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:I.21, A:F.149, A:A.191 Hydrogen bonds: A:G.14, A:G.14, A:I.21, A:D.64, A:V.65, A:I.95, A:G.96, A:K.165, A:I.194, A:I.194, A:T.196, A:T.196, A:A.198 pi-Stacking: A:F.41 NAD.3: 26 residues within 4Å: Chain B: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, M.161, K.165, A.191, G.192, P.193, I.194, T.196, A.198, M.199 Ligands: 9W2.2 19 PLIP interactions: 19 interactions with chain B Hydrophobic interactions: B:I.21, B:F.149, B:A.191 Hydrogen bonds: B:G.14, B:S.20, B:I.21, B:D.64, B:V.65, B:I.95, B:G.96, B:K.165, B:I.194, B:I.194, B:T.196, B:T.196 Water bridges: B:A.22, B:F.41, B:F.41 pi-Stacking: B:F.41 NAD.5: 25 residues within 4Å: Chain C: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, M.161, K.165, A.191, G.192, P.193, I.194, T.196, M.199 Ligands: 9W2.4 18 PLIP interactions: 18 interactions with chain C Hydrophobic interactions: C:I.21, C:F.149, C:A.191 Hydrogen bonds: C:G.14, C:S.20, C:I.21, C:D.64, C:D.64, C:V.65, C:I.95, C:G.96, C:K.165, C:I.194, C:I.194, C:T.196 Water bridges: C:A.22, C:I.95 pi-Stacking: C:F.41 NAD.7: 24 residues within 4Å: Chain D: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, M.161, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: 9W2.6 17 PLIP interactions: 17 interactions with chain D Hydrophobic interactions: D:I.21, D:F.149, D:A.191 Hydrogen bonds: D:G.14, D:I.21, D:D.64, D:D.64, D:V.65, D:I.95, D:G.96, D:K.165, D:I.194, D:I.194, D:T.196 Water bridges: D:T.17, D:A.198 pi-Stacking: D:F.41

3 x 9W2: ~{N}-(1-pyrimidin-2-ylpiperidin-4-yl)ethanamide(Non-covalent)

9W2.2: 10 residues within 4Å: Chain B: G.96, F.97, M.98, M.103, Y.158, M.161, A.198, M.199, I.202 Ligands: NAD.3 3 PLIP interactions: 3 interactions with chain B Hydrophobic interactions: B:F.97, B:Y.158 Hydrogen bonds: B:M.98 9W2.4: 8 residues within 4Å: Chain C: G.96, F.97, M.98, M.103, Y.158, M.161, M.199 Ligands: NAD.5 3 PLIP interactions: 3 interactions with chain C Hydrophobic interactions: C:F.97, C:Y.158 Hydrogen bonds: C:M.98 9W2.6: 8 residues within 4Å: Chain D: G.96, F.97, M.98, M.103, Y.158, M.161, M.199 Ligands: NAD.7 2 PLIP interactions: 2 interactions with chain D Hydrophobic interactions: D:Y.158 Hydrogen bonds: D:M.98

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Prati, F. et al., Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA. ChemMedChem (2018)

Release Date

2018-02-14

Peptides

Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Enoyl-[acyl-carrier-protein] reductase [NADH]

Related Entries With Identical Sequence